02171 CARSGEN-B
- 9.000
- -0.080-0.88%
CARSGEN-B News
CARSGEN-B: TERMS OF REFERENCE FOR THE AUDIT COMMITTEE
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - UPDATED RESEARCH RESULTS ON ZEVOR-CEL, CT071 AND CT0590 AT ASH 2024 ANNUAL CONGRESS
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
CARSGEN-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHAREOPTION SCHEME
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - LIFT OF THE U.S. CLINICAL HOLDS FOR ZEVORCABTAGENE AUTOLEUCEL, SATRICABTAGENE AUTOLEUCEL AND CT071 BY FDA
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - TO PRESENT ZEVORCABTAGENE AUTOLEUCEL, CT071 AND CT0590 AT ASH 2024 ANNUAL CONGRESS
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - APPLICATION TO REQUEST LIFTING CLINICALHOLDS SUBMITTED TO FDA
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
CARSGEN-B: INTERIM REPORT 2024
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
CARSGEN-B: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OFCONFIRMATORY PHASE II CLINICAL TRIAL OFSATRICABTAGENE AUTOLEUCEL IN CHINA
CARSGEN-B: DATE OF BOARD MEETING
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: VOLUNTARY ANNOUNCEMENT -SHAREHOLDING INCREASE BY THE SUBSTANTIAL SHAREHOLDERAND SHARE REPURCHASE BY THE COMPANY
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
No Data
